Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 3 studies | 24% ± 3% | |
| epithelial cell | 3 studies | 18% ± 2% | |
| GABAergic neuron | 3 studies | 31% ± 4% | |
| glutamatergic neuron | 3 studies | 33% ± 6% | |
| astrocyte | 3 studies | 25% ± 10% | |
| oligodendrocyte | 3 studies | 23% ± 7% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 26% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 3564.41 | 1445 / 1445 | 100% | 14.54 | 183 / 183 |
| prostate | 100% | 4655.56 | 245 / 245 | 100% | 15.34 | 501 / 502 |
| bladder | 100% | 4171.52 | 21 / 21 | 100% | 10.92 | 502 / 504 |
| breast | 100% | 3796.43 | 459 / 459 | 99% | 16.29 | 1112 / 1118 |
| thymus | 100% | 4447.51 | 653 / 653 | 99% | 14.22 | 601 / 605 |
| skin | 100% | 3226.46 | 1808 / 1809 | 99% | 16.99 | 469 / 472 |
| intestine | 100% | 4579.13 | 966 / 966 | 99% | 10.45 | 522 / 527 |
| uterus | 100% | 4996.36 | 170 / 170 | 99% | 11.88 | 453 / 459 |
| lung | 100% | 3920.84 | 577 / 578 | 99% | 12.17 | 1139 / 1155 |
| pancreas | 100% | 2912.10 | 328 / 328 | 98% | 10.26 | 175 / 178 |
| stomach | 100% | 3407.58 | 358 / 359 | 98% | 11.33 | 280 / 286 |
| kidney | 100% | 2825.43 | 89 / 89 | 97% | 11.22 | 874 / 901 |
| adrenal gland | 100% | 6384.40 | 258 / 258 | 96% | 10.91 | 221 / 230 |
| brain | 96% | 1849.07 | 2548 / 2642 | 100% | 15.68 | 702 / 705 |
| ovary | 100% | 4438.69 | 180 / 180 | 93% | 9.46 | 398 / 430 |
| liver | 97% | 1397.81 | 220 / 226 | 74% | 4.74 | 299 / 406 |
| adipose | 100% | 3491.68 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 5147.80 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 100% | 7409.58 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 13.22 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 3.97 | 1 / 1 |
| muscle | 99% | 2023.00 | 792 / 803 | 0% | 0 | 0 / 0 |
| heart | 97% | 1889.93 | 839 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 96% | 10.34 | 77 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 93% | 12.85 | 27 / 29 |
| peripheral blood | 85% | 1858.18 | 786 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006974 | Biological process | DNA damage response |
| GO_0030282 | Biological process | bone mineralization |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0005634 | Cellular component | nucleus |
| GO_0003677 | Molecular function | DNA binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0003674 | Molecular function | molecular_function |
| Gene name | ZBTB40 |
| Protein name | Zinc finger and BTB domain containing 40, isoform CRA_a (cDNA, FLJ95610, Homo sapiens KIAA0478 gene product (KIAA0478), mRNA) Zinc finger and BTB domain-containing protein 40 ZBTB40 protein Zinc finger and BTB domain containing 40 |
| Synonyms | KIAA0478 hCG_1812845 |
| Description | FUNCTION: May be involved in transcriptional regulation. |
| Accessions | ENST00000650433.1 A0A3B3IRZ6 ENST00000400239.6 F8WAI8 ENST00000374651.8 ENST00000375647.5 [Q9NUA8-1] B1AKC8 B2RBP0 Q1RMZ5 Q9NUA8 ENST00000404138.5 [Q9NUA8-1] |
